Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
Nat Commun ; 15(1): 2866, 2024 Apr 03.
Article En | MEDLINE | ID: mdl-38570482

Traumatic brain injury leads to a highly orchestrated immune- and glial cell response partially responsible for long-lasting disability and the development of secondary neurodegenerative diseases. A holistic understanding of the mechanisms controlling the responses of specific cell types and their crosstalk is required to develop an efficient strategy for better regeneration. Here, we combine spatial and single-cell transcriptomics to chart the transcriptomic signature of the injured male murine cerebral cortex, and identify specific states of different glial cells contributing to this signature. Interestingly, distinct glial cells share a large fraction of injury-regulated genes, including inflammatory programs downstream of the innate immune-associated pathways Cxcr3 and Tlr1/2. Systemic manipulation of these pathways decreases the reactivity state of glial cells associated with poor regeneration. The functional relevance of the discovered shared signature of glial cells highlights the importance of our resource enabling comprehensive analysis of early events after brain injury.


Brain Injuries , Wounds, Stab , Animals , Mice , Male , Glial Fibrillary Acidic Protein/metabolism , Neuroglia/metabolism , Brain Injuries/metabolism , Cerebral Cortex/metabolism , Wounds, Stab/complications , Wounds, Stab/metabolism
2.
EMBO Mol Med ; 14(5): e14797, 2022 05 09.
Article En | MEDLINE | ID: mdl-35373464

Direct reprogramming based on genetic factors resembles a promising strategy to replace lost cells in degenerative diseases such as Parkinson's disease. For this, we developed a knock-in mouse line carrying a dual dCas9 transactivator system (dCAM) allowing the conditional in vivo activation of endogenous genes. To enable a translational application, we additionally established an AAV-based strategy carrying intein-split-dCas9 in combination with activators (AAV-dCAS). Both approaches were successful in reprogramming striatal astrocytes into induced GABAergic neurons confirmed by single-cell transcriptome analysis of reprogrammed neurons in vivo. These GABAergic neurons functionally integrate into striatal circuits, alleviating voluntary motor behavior aspects in a 6-OHDA Parkinson's disease model. Our results suggest a novel intervention strategy beyond the restoration of dopamine levels. Thus, the AAV-dCAS approach might enable an alternative route for clinical therapies of Parkinson's disease.


Parkinson Disease , Animals , Astrocytes , Corpus Striatum , Dopamine , Dopaminergic Neurons , GABAergic Neurons , Mice , Parkinson Disease/genetics , Parkinson Disease/therapy
3.
EMBO J ; 40(21): e107532, 2021 11 02.
Article En | MEDLINE | ID: mdl-34549820

Astrocytes regulate brain-wide functions and also show region-specific differences, but little is known about how general and region-specific functions are aligned at the single-cell level. To explore this, we isolated adult mouse diencephalic astrocytes by ACSA-2-mediated magnetic-activated cell sorting (MACS). Single-cell RNA-seq revealed 7 gene expression clusters of astrocytes, with 4 forming a supercluster. Within the supercluster, cells differed by gene expression related to ion homeostasis or metabolism, with the former sharing gene expression with other regions and the latter being restricted to specific regions. All clusters showed expression of proliferation-related genes, and proliferation of diencephalic astrocytes was confirmed by immunostaining. Clonal analysis demonstrated low level of astrogenesis in the adult diencephalon, but not in cerebral cortex grey matter. This led to the identification of Smad4 as a key regulator of diencephalic astrocyte in vivo proliferation and in vitro neurosphere formation. Thus, astrocytes show diverse gene expression states related to distinct functions with some subsets being more widespread while others are more regionally restricted. However, all share low-level proliferation revealing the novel concept of adult astrogenesis in the diencephalon.


Astrocytes/metabolism , Cell Lineage/genetics , Diencephalon/metabolism , Gene Expression Regulation, Developmental , Neurogenesis/genetics , Smad4 Protein/genetics , Animals , Astrocytes/classification , Astrocytes/cytology , Cell Cycle/genetics , Cell Differentiation , Cell Proliferation , Cerebral Cortex/cytology , Cerebral Cortex/growth & development , Cerebral Cortex/metabolism , Diencephalon/cytology , Diencephalon/growth & development , Gene Ontology , Gene Regulatory Networks , Gray Matter/cytology , Gray Matter/growth & development , Gray Matter/metabolism , Metabolic Networks and Pathways , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Annotation , Multigene Family , Signal Transduction , Smad4 Protein/metabolism
4.
Cell ; 184(3): 709-722.e13, 2021 02 04.
Article En | MEDLINE | ID: mdl-33482084

Neural stem cells (NSCs) in the adult brain transit from the quiescent state to proliferation to produce new neurons. The mechanisms regulating this transition in freely behaving animals are, however, poorly understood. We customized in vivo imaging protocols to follow NSCs for several days up to months, observing their activation kinetics in freely behaving mice. Strikingly, NSC division is more frequent during daylight and is inhibited by darkness-induced melatonin signaling. The inhibition of melatonin receptors affected intracellular Ca2+ dynamics and promoted NSC activation. We further discovered a Ca2+ signature of quiescent versus activated NSCs and showed that several microenvironmental signals converge on intracellular Ca2+ pathways to regulate NSC quiescence and activation. In vivo NSC-specific optogenetic modulation of Ca2+ fluxes to mimic quiescent-state-like Ca2+ dynamics in freely behaving mice blocked NSC activation and maintained their quiescence, pointing to the regulatory mechanisms mediating NSC activation in freely behaving animals.


Adult Stem Cells/metabolism , Calcium/metabolism , Circadian Rhythm , Intracellular Space/metabolism , Neural Stem Cells/metabolism , Adult Stem Cells/cytology , Adult Stem Cells/drug effects , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Behavior, Animal/drug effects , Cell Division/drug effects , Cell Proliferation/drug effects , Circadian Rhythm/drug effects , Cytosol/metabolism , Epidermal Growth Factor/pharmacology , Inositol 1,4,5-Trisphosphate Receptors/metabolism , Melatonin/metabolism , Mice , Neural Stem Cells/cytology , Neural Stem Cells/drug effects , Optogenetics , Signal Transduction/drug effects , Tryptamines/pharmacology
5.
Cell Stem Cell ; 26(2): 277-293.e8, 2020 02 06.
Article En | MEDLINE | ID: mdl-32032526

The mammalian brain contains few niches for neural stem cells (NSCs) capable of generating new neurons, whereas other regions are primarily gliogenic. Here we leverage the spatial separation of the sub-ependymal zone NSC niche and the olfactory bulb, the region to which newly generated neurons from the sub-ependymal zone migrate and integrate, and present a comprehensive proteomic characterization of these regions in comparison to the cerebral cortex, which is not conducive to neurogenesis and integration of new neurons. We find differing compositions of regulatory extracellular matrix (ECM) components in the neurogenic niche. We further show that quiescent NSCs are the main source of their local ECM, including the multi-functional enzyme transglutaminase 2, which we show is crucial for neurogenesis. Atomic force microscopy corroborated indications from the proteomic analyses that neurogenic niches are significantly stiffer than non-neurogenic parenchyma. Together these findings provide a powerful resource for unraveling unique compositions of neurogenic niches.


Neural Stem Cells , Proteome , Animals , Neurogenesis , Proteomics , Stem Cell Niche
...